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Managing functional disorders: opportunities and threats
Approximately, 10–15% of patients treated by general
practitioners (GPs) consult because of symptoms that
cannot be easily diagnosed with existing diagnostic cod-
ing systems. These symptoms have been called ‘medically
unexplained physical symptoms’, ‘MUPS’ or ‘MUS’, and
especially in North America as ‘somatic symp-
tom disorders’.
The Research Clinic for Functional Disorders and
Psychosomatics in Aarhus, Denmark is a GP led clinic that
pursues a research agenda in this field. It has applied the
terms ‘functional disorders’, ‘health anxiety’ and ‘bodily
distress syndrome’, which is also a new ICD-11 code. A
lot of criticism from patient organizations has been
focused on the term ‘functional disorders’ and all psycho-
logical treatments for them. The criticism stems from
some patient representatives still believing these disor-
ders to have a solely biological origin. Chronic fatigue
syndrome (CFS) and its causes are particularly debated.
However, an increasing amount of research evidence
exists to support the term ‘functional’ instead of medic-
ally unexplained [1,2]. These disorders most likely have a
multifactorial origin, including genetic, predisposing and
triggering factors. Stress is prevalent [3], and even toxic
stress experienced in childhood is linked to these condi-
tions [4]. The central mechanism in functional disorders
appears to be a sensitization of the central nervous sys-
tem, which can cause a multitude of symptoms from the
overactive autonomous nervous system [2]. Recent imag-
ing studies that used functional MRI, support this the-
ory [1].
A worrying phenomenon is that researchers working
on functional disorders, especially CFS, face harsh online
abuse and harassment. Like many leading scientists,
Michael Sharpe, an Oxford based psychologist, quit the
CFS research last year saying that the field had become
‘too toxic’ [5]. Guidelines editors and health policy makers
have experienced similar campaigning from the
CFS community.
Another threat is the increasing shortage of continuity
of care in general practice. In Denmark, the number of
GPs decreases while population ages and the demands
increase [6]. Similarly, in Norway, there is an ongoing
recruitment crisis of GPs [7]. In Finland, a health care
reform has been attempted for 15 years to improve the
suffering primary health care, without success. Continuity
of care and the context of general practice are crucial for
diagnostic knowing [8], a basic skill needed with the
complex functional disorders.
A third challenge relates to potential medical overuse.
Patients with functional disorders cause diagnostic chal-
lenges and often experience excessive diagnostic testing,
which is another and costly threat in their management.
Medical overuse is a dilemma for GPs, and they under-
stand the potential harm it may cause to patients [9].
Excessive testing, uncertainty and negative expectations
cause harmful nocebo effects that can develop into som-
atic symptoms and anxiety [10].
On the other hand, the placebo-nocebo research pro-
vides new insights into the patient encounter [11]. With
functional disorders, explaining the nocebo effects may
help patient understand the worsening of symptoms.
Focusing less on symptoms and more on cure reduces
the nocebo effects. At the same time, the placebo effects
such as trust, hope, continuity of care and good commu-
nication form essential parts of the cure.
Finally, the term ‘functional’ may also entail optimism.
It means that no permanent injury has taken place and
that the disorder is reversible. The sensitized central ner-
vous system may be retrained. To help educating
patients in this process, there are useful Internet resour-
ces such as the site created by the Scottish neurologist
Jon Stone: neurosymptoms.org. A patient organization,
FND Hope, empowers and supports patients with func-
tional neurological disorders.
There is evidence from a Cochrane review that cogni-
tive behavioral therapy (CBT) reduces somatic symptoms
[12]. However, CBT is not widely available and modifica-
tions suitable for large groups of patients are necessary.
Psychoeducation in groups can alleviate the symptoms in
these patients [13]. Web-based, guided self-help is
another promising alternative [14]. Nevertheless, general
practice needs courageous researchers and further devel-
opment of interventions to tackle the burden of illness
by functional disorders.
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